Sheridan Capital Partners Invests in Dermatologists of Central States
Summary
Sheridan Capital Partners, a Chicago-based lower middle-market private equity firm, has made an investment in Dermatologists of Central States, a Dayton, OH-based dermatology practice management company.Lewis continued, “We are grateful that Dr. Stephen Levitt and Dr. Thomas Olsen chose to partner with us, and we look forward to continuing their legacy of clinical excellence.” Sean Dempsey, Managing Director of Sheridan added, “We have been actively seeking an investment opportunity within the dermatology space for the past two years and are delighted to partner with John Macke, Dr. Michael Conroy, the entire DOCS management team and the numerous providers working with DOCS.” John Macke, CEO of DOCS, said, “Sheridan represents a perfect partner for us.The investment team has extensive experience adding value to and growing within the practice management framework, a hands-on operational approach, and a deep understanding of the healthcare industry.” Dr. Michael Conroy, Chief Medical Officer of DOCS, added, “With Sheridan, we saw the opportunity to build a practice model that allows clinicians to focus on providing the highest levels of care with minimal disruption to existing treatment modalities at the practice level.” The transaction was led by Lewis, Dempsey, Tim Wheeler, and Beau Brace.SCP focuses on lower middle market buyouts and growth equity investments across the consumer health sector in the U.S. and Canada with enterprise values from $25 million to $150 million, bringing strategic resources to management teams and owners to help accelerate growth, build enduring value, and achieve superior results.For over 40 years, DOCS’ partner practices have established a reputation for providing excellent clinical care and an elevated patient experience within the communities they serve.